Evidence map›Paper›PMID 41978689›Full record

ArticleRheumatology advances in practice2026

Feasibility study of a smartphone app to monitor systemic sclerosis-related digital ulcers-a potential new tool for remote clinical monitoring.

Paul New, Graham Dinsdale, Andy Vail, Joanne Manning, Michael Hughes, William G Dixon, Chris Taylor, Mark Dickinson, Ariane L Herrick, Andrea Murray

Abstract read
In one paragraph

Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul NewCentre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Graham DinsdaleRheumatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.ORCID https://orcid.org/0000-0001-6245-2721
Andy VailCentre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Joanne ManningRheumatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Michael HughesCentre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
William G DixonRheumatology Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.ORCID https://orcid.org/0000-0001-5881-4857
Chris TaylorSchool of Engineering and School of Health Sciences, The University of Manchester, Manchester, UK.
Mark DickinsonPhoton Science Institute, The University of Manchester, Manchester, UK.
Ariane L HerrickCentre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.ORCID https://orcid.org/0000-0003-4941-7926
Andrea MurrayCentre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.ORCID https://orcid.org/0000-0001-9244-2882

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To assess the feasibility, in a clinical setting, of using a smartphone app that allows 'tracking' of SSc-related digital ulcers/lesions over time and to gauge patient opinion of the app's benefits, including a newly added lesion feedback function for patients. Methods: Patients with SSc with active digital ulcers/lesions were recruited and assessed twice: on study entry and at the point of lesion healing. Participants photographed their lesions and recorded patient-reported outcome measures (PROMs) with the app twice weekly. The lesion feedback function showed lesion size (measured from the photographs) over time. Ways in which feasibility was assessed included the number of photographs and PROMS recorded via the app, data from patient questionnaires and verbal feedback. Results: A total of 10 patients were recruited: 9 (90%) female, median age 55 years, median disease duration 12 years. Nine (90%) completed the study. The median duration of study participation per 'lesion episode' was 39 days (range 18-140). A total of 210 images were returned, with a median of 12 (range 4-87) per episode, and 99 sets of visual analogue scale/pain scores were returned, with a median of 7 (range 3-24) per episode. On a scale of 1 (very easy/helpful) to 10 (very difficult/not helpful), the median score for ease of sending photographs was 1 (range 1-3) and for helpfulness of feedback it was 1.5 (range 1-8). All patients were keen to use the app again. Conclusion: The feasibility and benefits of using the smartphone app, including the feedback function, lend support to possible wider use of the app in routine clinical practice.

Indexed as

digital ulcerssclerodermasmartphone appsmartphone photographysystemic sclerosis

Identifiers

PMID41978689
PMCPMC13070691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.